Chris Cooper

Work Performance Price Targets & Ratings Chart

Analyst Chris Cooper, currently employed at GOLDMAN SACHS,

Most recent stock forecast was given on RMD, ResMed at 02-Nov-2025.

Wall Street Analyst Chris Cooper

Analyst best performing recommendations are on RMD (RESMED).
RMD ResMed

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$300

$53.12 (21.52%)

$270

2 days ago
(31-Oct-2025)

14/15 (93.33%)

$53.12 (21.52%)

98

Buy

$304

$57.12 (23.14%)

$219

12 days ago
(21-Oct-2025)

6/7 (85.71%)

$35.78 (13.34%)

73

Buy

$330

$83.12 (33.67%)

$285

1 months 15 days ago
(18-Sep-2025)

7/8 (87.5%)

$56.71 (20.75%)

38

Buy

$290

$43.12 (17.47%)

6 months 9 days ago
(24-Apr-2025)

17/17 (100%)

$54.9 (23.35%)

363

Hold

$248

$1.12 (0.45%)

$260

6 months 9 days ago
(24-Apr-2025)

3/3 (100%)

$12.9 (5.49%)

70

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?